6,510
Views
18
CrossRef citations to date
0
Altmetric
Report

Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform

ORCID Icon, , ORCID Icon, , , , ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 666-680 | Received 23 Jan 2019, Accepted 12 Mar 2019, Published online: 03 May 2019

References

  • Carter PJ, Lazar GA. Next generation antibody drugs: pursuit of the ‘high-hanging fruit’. Nat Rev Drug Discov. 2018;17(3):197–223. doi:10.1038/nrd.2017.227. PMID: 29192287.
  • William R. Strohl Current progress in innovative engineered antibodies. Protein Cell. 2018;9(1):86–120. doi:10.1007/s13238-017-0457-8. PMID: 28822103.
  • Green LL. Transgenic mouse strains as platforms for the successful discovery and development of human therapeutic monoclonal antibodies. Curr Drug Discov Technol. 2014;11(1):74–84. PMID: 23978036.
  • Frenzel A, Schirrmann T, Hust M. Phage display-derived human antibodies in clinical development and therapy. MAbs. 2016;8(7):1177–94. doi:10.1080/19420862.2016.1212149. PMID: 27416017.
  • International Chicken Genome Sequencing Consortium. Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature. 2004;432(7018):695–716. Erratum in: Nature. 2005 433(7027):777. doi:10.1038/nature03154. PMID: 15592404.
  • Hedges SB, Marin J, Suleski M, Paymer M, Kumar S. Tree of life reveals clock-like speciation and diversification. Mol Biol Evol. 2015;32(4):835–45. doi:10.1093/molbev/msv037. PMID: 25739733 PMCID: PMC4379413.
  • Parvari R1, Avivi A, Lentner F, Ziv E, Tel-Or S, Burstein Y, Schechter I. Chicken immunoglobulin gamma-heavy chains: limited VH gene repertoire, combinatorial diversification by D gene segments and evolution of the heavy chain locus. Embo J. 1988;7(3):739–44. PMID: 3135182 PMCID: PMC454383.
  • Reynaud CA, Dahan A, Anquez V, Weill JC. Somatic hyperconversion diversifies the single Vh gene of the chicken with a high incidence in the D region. Cell. 1989;59(1):171–83. PMID: 2507167.
  • Ratcliffe MJ. Antibodies, immunoglobulin genes and the bursa of Fabricius in chicken B cell development. Dev Comp Immunol. 2006;30(1–2):101–18. doi:10.1016/j.dci.2005.06.018. PMID: 16139886.
  • Wu L, Oficjalska K, Lambert M, Fennell BJ, Darmanin-Sheehan A, Ní Shúilleabháin D, Autin B, Cummins E, Tchistiakova L, Bloom L, et al. Fundamental characteristics of the immunoglobulin VH repertoire of chickens in comparison with those of humans, mice, and camelids. J Immunol. 2012;188(1):322–33. doi:10.4049/jimmunol.1102466. PMID: 22131336.
  • Abdiche YN, Harriman R, Deng X, Yeung YA, Miles A, Morishige W, Boustany L, Zhu L, Izquierdo SM, Harriman W. Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms. MAbs. 2016;8(2):264–77. doi:10.1080/19420862.2015.1118596. PMID: 26652308.
  • Meijer PJ, Andersen PS, Haahr Hansen M, Steinaa L, Jensen A, Lantto J, Oleksiewicz MB, Tengbjerg K, Poulsen TR, Coljee VW, et al. Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. J Mol Biol. 2006;358(3):764–72. doi:10.1016/j.jmb.2006.02.040. PMID: 16563430.
  • Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. Embo J. 1992;11(11):3887–95. PMID: 1396582 PMCID: PMC556898.
  • Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Int Immunol. 1996;8(5):765–72. PMID: 8671665.
  • Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252–64. doi:10.1038/nrc3239. PMID: 22437870.
  • Okazaki T, Chikuma S, Iwai Y, Fagarasan S, Honjo T. A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. Nat Immunol. 2013 Dec;14(12):1212–18. doi:10.1038/ni.2762. PMID: 24240160.
  • Gong J, Chehrazi-Raffle A, Reddi S, Salgia R. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer. 2018;6:8. doi:10.1186/s40425-018-0316-z. PMCID: PMC5778665 PMID: 29357948.
  • Hezareh M, Hessell AJ, Jensen RC, van de Winkel JG, Parren PW. Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1. J Virol. 2001;75(24):12161–68. doi:10.1128/JVI.75.24.12161-12168.2001. PMID: 11711607.
  • Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 2007;449(7158):101–04. doi:10.1038/nature06106. PMID: 17805298.
  • Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al. scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7:539. doi:10.1038/msb.2011.75. PMID:21988835.
  • Könitzer JD, Pramanick S, Pan Q, Augustin R, Bandholtz S, Harriman W, Izquierdo S. Generation of a highly diverse panel of antagonistic chicken monoclonal antibodies against the GIP receptor. MAbs. 2017;9(3):536–49. doi:10.1080/19420862.2016.1276683. PMID: 28055305.
  • Shi B, Ma L, He X, Wang X, Wang P, Zhou L, Yao X. Comparative analysis of human and mouse immunoglobulin variable heavy regions from IMGT/LIGM-DB with IMGT/HighV-QUEST. Theor Biol Med Model. 2014;11:30. doi:10.1186/1742-4682-11-30. PMID: 24992938.
  • Buchanan A, Clementel V, Woods R, Harn N, Bowen MA, Mo W, Popovic B, Bishop SM, Dall’Acqua W, Minter R, et al. Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression. MAbs. 2013;5(2):255–62. doi:10.4161/mabs.23392. PMID: 23412563.
  • Jarasch A, Koll H, Regula JT, Bader M, Papadimitriou A, Kettenberger H. Developability assessment during the selection of novel therapeutic antibodies. J Pharm Sci. 2015;104(6):1885–98. doi:10.1002/jps.24430. PMID: 25821140.
  • Jones PT, Dear PH, Foote J, Neuberger MS, Winter G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature. 1986;321(6069):522–25. doi:10.1038/321522a0. PMID: 3713831.
  • Foote J, Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol. 1992;224:487–99. doi:10.1016/0022-2836(92)91010-M. PMID: 1560463.
  • Sela-Culang I, Kunik V, Ofran Y. The structural basis of antibody-antigen recognition. Front Immunol. 2013;4:302. doi:10.3389/fimmu.2013.00302. PMID: 24115948.
  • Townsend S, Fennell BJ, Apgar JR, Lambert M, McDonnell B, Grant J, Wade J, Franklin E, Foy N, Ní Shúilleabháin D, et al. Augmented binary substitution: single-pass CDR germ-lining and stabilization of therapeutic antibodies. Proc Natl Acad Sci U S A. 2015;112(50):15354–59. doi:10.1073/pnas.1510944112. PMID: 26621728.
  • Lin DY, Tanaka Y, Iwasaki M, Gittis AG, Su HP, Mikami B, Okazaki T, Honjo T, Minato N, Garboczi DN. The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci U S A. 2008;105(8):3011–16. doi:10.1073/pnas.0712278105. PMID: 18287011.
  • Zak KM, Kitel R, Przetocka S, Golik P, Guzik K, Musielak B, Dömling A, Dubin G, Holak TA. Structure of the complex of human programmed death 1, PD1, and Its Ligand PD-L1. Structure. 2015;23(12):2341–48. doi:10.1016/j.str.2015.09.010. PMID: 26602187.
  • Tan S, Zhang H, Chai Y, Song H, Tong Z, Wang Q, Qi J, Wong G, Zhu X, Liu WJ, et al. An unexpected N-terminal loop in PD1 dominates binding by nivolumab. Nat Commun. 2017;8:14369. doi:10.1038/ncomms14369. PMID: 28165004.
  • Carroll SB, Stollar BD. Antibodies to calf thymus RNA polymerase II from egg yolks of immunized hens. J Biol Chem. 1983 Jan 10;258(1):24–26. PMID: 6336747.
  • Gassmann M, Thömmes P, Weiser T, Hübscher U. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 1990;4(8):2528–32. PMID: 1970792.
  • Tucker DF, Sullivan JT, Mattia KA, Fisher CR, Barnes T, Mabila MN, Wilf R, Sulli C, Pitts M, Payne RJ, et al. Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles. Proc Natl Acad Sci U S A. 2018;115(22):E4990–E4999. doi:10.1073/pnas.1716788115. PMID: 29769329.
  • Li D, Xu J, Wang Z, Gong Z, Liu J, Zheng Y, Li J. Epitope mapping reveals the binding mechanism of a functional antibody cross-reactive to both human and murine programmed death 1. MAbs. 2017;9(4):628–37. doi:10.1080/19420862.2017.1296612. PMID: 28300475.
  • Andris-Widhopf J, Rader C, Steinberger P, Fuller R, Barbas CF. Methods for the generation of chicken monoclonal antibody fragments by phage display. J Immunol Methods. 2000;242(1–2):159–81. PMID: 10986398.
  • Tsurushita N, Park M, Pakabunto K, Ong K, Avdalovic A, Fu H, Jia A, Vásquez M, Kumar S. Humanization of a chicken anti-IL-12 monoclonal antibody. J Immunol Methods PMID: 15627607. 2004;295(1–2):9–19. doi:10.1016/j.jim.2004.08.018.
  • Ching KH, Collarini EJ, Abdiche YN, Bedinger D, Pedersen D, Izquierdo S, Harriman R, Zhu L, Etches RJ, van de Lavoir MC, et al. Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targets. MAbs. 2018;10(1):71–80. doi:10.1080/19420862.2017.1386825. PMID: 29035625.
  • Sorouri M, Fitzsimmons SP, Aydanian AG, Bennett S, Shapiro MA. Diversity of the antibody response to tetanus toxoid: comparison of hybridoma library to phage display library. PLoS One. 2014;9(9):e106699. doi:10.1371/journal.pone.0106699. PMID: 25268771.
  • Adler AS, Bedinger D, Adams MS, Asensio MA, Edgar RC, Leong R1, Leong J, Ra M, Mj S, Sr B, et al. A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody library. MAbs. 2018;10(3):431–43. doi:10.1080/19420862.2018.1426422. PMID: 29376776.
  • West AP Jr, Scharf L, Scheid JF, Klein F, Bjorkman PJ, Nussenzweig MC. Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell. 2014;156(4):633–48. doi:10.1016/j.cell.2014.01.052. PMID: 24529371.
  • Sok D, Le KM, Vadnais M, Saye-Francisco KL, Jardine JG, Torres JL, Berndsen ZT, Kong L, Stanfield R, Ruiz J, et al. Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows. Nature. 2017;548(7665):108–11. doi:10.1038/nature23301. PMID: 28726771.
  • Patnaik A, Kang SP, Rasco D, Papadopoulos KP, Elassaiss-Schaap J, Beeram M, Drengler R, Chen C, Smith L, Espino G, et al. Phase I study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in patients with advanced solid tumors. Clin Cancer Res. 2015;21(19):4286–93. doi:10.1158/1078-0432.CCR-14-2607. PMID: 25977344.
  • Lindauer A, Valiathan CR, Mehta K, Sriram V, de Greef R, Elassaiss-Schaap J, de Alwis DP. Translational pharmacokinetic/pharmacodynamic modeling of tumor growth inhibition supports dose-range selection of the anti-PD-1 antibody pembrolizumab. CPT Pharmacometrics Syst Pharmacol. 2017;1:11–20. doi:10.1002/psp4.12130. PMID: 27863176.
  • Zemlin M, Klinger M, Link J, Zemlin C, Bauer K, Engler JA, Schroeder HW Jr, Kirkham PM. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol. 2003;334(4):733–49. PMID: 14636599.
  • Lantto J, Haahr Hansen M, Rasmussen SK, Steinaa L, Poulsen TR, Duggan J, Dennis M, Naylor I, Easterbrook L, Bregenholt S, et al. Capturing the natural diversity of the human antibody response against vaccinia virus. J Virol. 2011;85(4):1820–33. doi:10.1128/JVI.02127-10. PMID: 21147924.
  • Akbari S1, Pirbodaghi T. A droplet-based heterogeneous immunoassay for screening single cells secreting antigen-specific antibodies. Lab Chip. 2014;14(17):3275–80. doi:10.1039/c4lc00082j. PMID: 24989431.
  • DeKosky BJ, Kojima T, Rodin A, Charab W, Ippolito GC, Ellington AD, Georgiou G. In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire. Nat Med. 2015 Jan;21(1):86–91. . doi:10.1038/nm.3743. PMID: 25501908.
  • Adler AS, Mizrahi RA, Spindler MJ, Adams MS, Asensio MA, Edgar RC, Leong J, Leong R, Johnson DS. Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics. MAbs. 2017a;9(8):1270–81. doi:10.1080/19420862.2017.1371386. PMID: 28846506.
  • Adler AS, Mizrahi RA, Spindler MJ, Adams MS, Asensio MA, Edgar RC, Leong J, Leong R, Roalfe L, White R, et al. Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomics. MAbs. 2017b;9(8):1282–96. doi:10.1080/19420862.2017.1371383. PMID: 28846502.
  • Wang B, DeKosky BJ, Timm MR, Lee J, Normandin E, Misasi J, Kong R, McDaniel JR, Delidakis G, Leigh KE, et al. Functional interrogation and mining of natively paired human VH:VL antibody repertoires. Nat Biotechnol. 2018;36(2):152–55. doi:10.1038/nbt.4052. PMID: 29309060.
  • Meijer PJ, Nielsen LS, Lantto J, Jensen A. Human antibody repertoires. Methods Mol Biol. 2009;525:261–77. doi:10.1007/978-1-59745-554-1_13. PMID: 19252857.
  • Baldi P, Chauvin Y, Hunkapiller T, McClure MA. Hidden Markov models of biological primary sequence information. Proc Natl Acad Sci U S A. 1994;91(3):1059–63. PMID: 8302831.
  • Koefoed K, Steinaa L, Søderberg JN, Kjær I, Jacobsen HJ, Meijer PJ, Haurum JS, Jensen A, Kragh M, Andersen PS, et al. Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor. MAbs. 2011;3(6):584–95. doi:10.4161/mabs.3.6.17955. PMID: 22123060.
  • Lefranc MP, Giudicelli V, Ginestoux C, Bodmer J, Müller W, Bontrop R, Lemaitre M, Malik A, Barbié V, Chaume D. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 1999;27(1):209–12. PMID: 9847182.
  • Rajan A, Kim C, Heery CR, Guha U, Gulley JL. Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: role in advanced cancers. Hum Vaccin Immunother. 2016;12(9):2219–31. doi:10.1080/21645515.2016.1175694. PMID: 27135835.
  • Kwok G, Yau TC, Chiu JW, Tse E, Kwong YL. Pembrolizumab (Keytruda). Hum Vaccin Immunother. 2016;12(11):2777–89. doi:10.1080/21645515.2016.1199310. PMID: 27398650.
  • Karlsson R. Biosensor binding data and its applicability to the determination of active concentration. Biophys Rev. 2016;8(4):347–58. doi:10.1007/s12551-016-0219-5. PMID: 28510014.